ProfileGDS4132 / 232020_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 16% 23% 28% 22% 19% 24% 21% 20% 27% 21% 22% 22% 23% 28% 22% 20% 21% 30% 23% 22% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10134.256816
GSM201543Muscle PCOS pioglitazone 12144.850523
GSM201544Muscle PCOS pioglitazone 16170.225628
GSM201545Muscle PCOS pioglitazone 20157.075422
GSM201829Muscle PCOS pioglitazone 23144.23919
GSM201830Muscle PCOS pioglitazon 25156.606724
GSM201831Muscle PCOS pioglitazone 27144.827921
GSM201832Muscle PCOS pioglitazone 3147.103220
GSM201833Muscle PCOS pioglitazone 4162.236827
GSM201834Muscle PCOS pioglitazone 8143.598121
GSM201835Muscle PCOS after pioglitazone 10239.695322
GSM201836Muscle PCOS after pioglitazone 12240.952422
GSM201837Muscle PCOS after pioglitazone 16242.708423
GSM201838Muscle PCOS after pioglitazone 20260.17728
GSM201839Muscle PCOS after pioglitazone 23244.727722
GSM201840Muscle PCOS after pioglitazone 25241.998420
GSM201841Muscle PCOS after pioglitazone 27235.838121
GSM201842Muscle PCOS after pioglitazone 3258.363830
GSM201843Muscle PCOS after pioglitazone 4251.434123
GSM201844Muscle PCOS after pioglitazone 8245.048922